Targeting Bacteria-Induced Ferroptosis of Bone Marrow Mesenchymal Stem Cells to Promote the Repair of Infected Bone...

Area of Science:

• Biomedical Engineering
• Stem Cell Biology
• Immunology

Background:

• Mechanisms of bacteria-induced bone marrow mesenchymal stem cell (BMSC) death and osteogenic dysfunction are unclear.
• Infected bone defects pose challenges for bone regeneration.
• Understanding BMSC death pathways is crucial for therapeutic development.

Purpose of the Study:

• To elucidate the mechanism of BMSC death in infected bone microenvironments.
• To identify ferroptosis as a key pathway in bacteria-induced BMSC death.
• To develop a therapeutic strategy targeting ferroptosis for infected bone defect repair.

Main Methods:

• Investigated BMSC death pathways in response to bacterial infection.
• Utilized molecular biology techniques to identify key regulatory factors (IRF7, ACSL4).
• Developed and tested a 3D-printed hydrogel scaffold delivering an antibacterial agent and ferroptosis inhibitor (Ferrostatin-1) in a rat model.

Main Results:

• Identified ferroptosis as the primary cause of BMSC death in infected bone defects.
• Demonstrated that bacterial infection upregulates IRF7, leading to ferroptosis via ACSL4.
• Showed that inhibiting ferroptosis partially rescues BMSC injury and osteogenic dysfunction.
• The 3D-printed scaffold effectively eradicated pathogens and promoted bone regeneration in vivo.

Conclusions:

• Ferroptosis is a critical mechanism underlying BMSC death and osteogenic dysfunction in infected bone defects.
• Targeting ferroptosis presents a promising therapeutic strategy for treating infected bone defects.
• A ROS-responsive hydrogel scaffold delivering an antibacterial agent and ferroptosis inhibitor can promote bone regeneration.